ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Periorbital oedema,Ocular disorders NEC,Eye disorders NEC,Eye,N
1,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
3,1,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
3,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
5,1,Headache,Headaches NEC,Headaches,Nerv,N
5,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
6,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
6,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
7,1,Migraine,Migraine headaches,Headaches,Nerv,N
8,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
9,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
10,1,Optic atrophy,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
11,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
